SDHB Peptide
€100.00
In stock
SKU
350503
Protein Family: Enzymes
Pathway and Disease: Cancers, Carbohydrate Metabolism, Energy Metabolism
Alternate Names: Succinate dehydrogenase ubiquinone iron-sulfur subunit; Ip; Iron-sulfur subunit of complex II; SDHB; SDH; SDH1
Accession No.: P21912
Description:
SDHB catalyzes the formation of fumarate from succinate. SDBH forms part of complex II containing four subunits: a flavoprotein, an iron-sulfur protein and a cytochrome b composed of two integral membrane proteins. Defects in SDBH are a cause of pheochromocytoma, an adrenal medulla cancer.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2077.3 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200141 is selected from a sequence within the N-term region of human SDHB. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C88H141N25O29S2
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
Pathway and Disease: Cancers, Carbohydrate Metabolism, Energy Metabolism
Alternate Names: Succinate dehydrogenase ubiquinone iron-sulfur subunit; Ip; Iron-sulfur subunit of complex II; SDHB; SDH; SDH1
Accession No.: P21912
Description:
SDHB catalyzes the formation of fumarate from succinate. SDBH forms part of complex II containing four subunits: a flavoprotein, an iron-sulfur protein and a cytochrome b composed of two integral membrane proteins. Defects in SDBH are a cause of pheochromocytoma, an adrenal medulla cancer.
Format:
Each vial contains 0.1 mg of lyophilized peptide. Reconstitute with 0.1 ml deionized water for a final concentration of 1 mg/ml. Use at 5.6 ug/ml for a 100X excess over antibody for maximum blocking effect.
MW: 2077.3 g/mol
Sequence:
The synthetic peptide used to raise the antibody Cat. No. 200141 is selected from a sequence within the N-term region of human SDHB. For blocking experiments, a 10 to 100 fold molar excess to antibody is recommended.
Composition:
C88H141N25O29S2
Purity:
> 80% by HPLC
Solubility:
Distilled water for a solution up to 2 mg/ml, otherwise we recommend using acetonitrile.
Storage:
Store at -20°C. The product is hygroscopic and must be protected from light. Product is guaranteed one year from the date of shipment. Following reconstitution, store at -20°C.
| Is Featured? | No |
|---|
Write Your Own Review